Advertisement
News
Subscribe to MDT Magazine News

Global Imaging Agents Industry

May 19, 2011 2:36 am | by Bio-Medicine.Org | Comments

NEW YORK, May 19, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Global Imaging Agents Industry...

TOPICS:

Reportlinker Adds Pharmaceutical Management of Obesity (Technical Insights)

May 19, 2011 1:45 am | by Bio-Medicine.Org | Comments

NEW YORK, May 19, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Pharmaceutical Management of Obesity (Technical Insights)...

TOPICS:

Takeda to Acquire Nycomed

May 18, 2011 11:37 pm | by Bio-Medicine.Org | Comments

OSAKA, Japan, and ZURICH, May 19, 2011 /- Takeda Pharmaceutical Company Limited ("Takeda", TSE: 4502) and Nycomed A/S ("Nycomed") jointly announced today that Takeda has reached an agreement with the shareholders of Nycomed in which Takeda will acquire the Zurich-headquartered company for...

TOPICS:
Advertisement

Images of a Hard-Hitting Disease

May 18, 2011 8:41 pm | by Massachusetts Institute of Technology | Comments

Advanced imaging techniques could help diagnose the degenerative brain disease linked to repetitive head trauma.

TOPICS:

Internal Fixation Systems, Inc. Announces Form S-1 Declared Effective by SEC and Anticipated Quotation for Trading on OTCQB

May 18, 2011 11:51 am | by Bio-Medicine.Org | Comments

SOUTH MIAMI, Fla., May 18, 2011 /- Internal Fixation Systems, Inc (IFS)announced today that its Registration Statement on Form S-1 (SEC File No.  333-170008) was declared effective by the Securities and Exchange Commission ("SEC") on May 15, 2011.  In addition and...

TOPICS:

Increased Demand for Visual Healthcare ADE Prevention Platform

May 18, 2011 11:49 am | by Bio-Medicine.Org | Comments

RENO, Nev., May 18, 2011 /- Visual Healthcare Corp. (the "Company") (NASDAQ OTC: VSHC) announces its decision to start selling a stand alone version of its powerful adverse drug event prevention technology to medical facilities and hospitals. The company is rolling out this new focused...

TOPICS:

OTC Industry Supports FDA Advisory Committee Recommendations on New Dosing Instructions

May 18, 2011 11:49 am | by Bio-Medicine.Org | Comments

WASHINGTON, May 18, 2011 /PRNewswire-USNewswire/ -- The Consumer Healthcare Products Association (CHPA), representing makers of over-the-counter (OTC) single-ingredient acetaminophen medicines for children, applauds the U.S. Food and Drug Administration (FDA) efforts to help parents and...

TOPICS:

Neuro Kinetics Releases Updated Version of Neuro-Otologic Control and Analysis Software

May 18, 2011 11:47 am | by Bio-Medicine.Org | Comments

PITTSBURGH, May 18, 2011 /- Neuro Kinetics, Inc. (NKI) ( www.neuro-kinetics.com ), manufacturers of noninvasive medical diagnostic equipment used worldwide for neuro-physiologic, neuro-otologic, vestibular and neurological testing, said today that it has released version 6.10 of its...

TOPICS:
Advertisement

Study Shows Improved Patient Management and Outcome Using Abbott's Sensitive Troponin Assay

May 18, 2011 11:46 am | by Bio-Medicine.Org | Comments

BERLIN, May 18, 2011 /- Research presented this week at the International Federation of Clinical Chemistry Congress and Laboratory Medicine showed that using a lower diagnostic threshold for troponin improves clinical outcomes and patient survival in patients with suspected acute coronary...

TOPICS:

Tepha pulls in $5M funding for absorbable medical devices

May 18, 2011 9:55 am | by Mass High Tech: The Journal of New England Technology | Comments

Lexington-based absorbable medical devices firm Tepha Inc. has raised $4.97 million of a planned $5.15 million equity financing, the company reported in a regulatory document.

TOPICS:

HealthSouth sells 6 hospitals in $120M deal

May 18, 2011 9:45 am | by The Associated Press | Comments

The Birmingham, Ala.-based HealthSouth Corp. said Wednesday that it is selling its six long-term, acute-care hospitals to LifeCare Holdings Inc. for about $120 million.HealthSouth announced the deal in a statement and said it will use proceeds from the sale to pay off debt.CEO Jay Grinney said...

Pearl Therapeutics' Phase 2b Results Show a 50% Improvement in Lung Function with PT003 Compared to Spiriva® and Foradil® in Patients with COPD

May 18, 2011 9:41 am | by Bio-Medicine.Org | Comments

REDWOOD CITY, Calif., May 18, 2011 /- Pearl Therapeutics Inc. presented detailed efficacy and safety results today from the Company's phase 2b study of PT003  (GFF MDI) in patients with moderate-to-very severe COPD during a late-breaker poster session at the annual meeting of the...

TOPICS:

ARX-01 and ARX-03 Clinical Results Presented at the 30th Annual Scientific Meeting of the American Pain Society

May 18, 2011 9:41 am | by Bio-Medicine.Org | Comments

REDWOOD CITY, Calif., May 18, 2011 /- AcelRx Pharmaceuticals, Inc. announced today that the results from its Phase 2 clinical studies related to two product candidates, ARX-01 Sufentanil NanoTab(R) PCA System, which is designed to solve the problems associated with post-operative...

TOPICS:

OBGYN Practices Refuse Obese Patients. Should You?

May 18, 2011 9:40 am | by Diagnostic Imaging | Comments

Some obstetricians are turning away obese patient, wary of the higher risk of complications and about the safety of patients on their exam tables. Radiology struggles with similar issues. Is it time to set limits?

TOPICS:

Cancer Drug Use and Spending to Rise Sharply by 2013

May 18, 2011 9:40 am | by Bio-Medicine.Org | Comments

ORLANDO, Fla., May 18, 2011 /- Expensive new cancer drugs treating increasing numbers of patients could drive cancer drug spending by as much as 15 percent a year through 2013. At this accelerated rate, oncology drugs will likely rise to the second or third largest trend-driving category...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading